Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical composition by Dalel Brahmi et al.
Brahmi et al. BMC Complementary and Alternative Medicine 2012, 12:111
http://www.biomedcentral.com/1472-6882/12/111RESEARCH ARTICLE Open AccessProtective effect of cactus cladode extract against
cisplatin induced oxidative stress, genotoxicity
and apoptosis in balb/c mice: combination
with phytochemical composition
Dalel Brahmi1,2, Yousra Ayed1, Mbarka Hfaiedh2, Chayma Bouaziz1, Hedi Ben Mansour3,
Lazhar Zourgui2,4 and Hassen Bacha1,5*Abstract
Background: Cis-Platinum (II) (cis-diammine dichloroplatinum; CDDP) is a potent antitumor compound widely used
for the treatment of many malignancies. An important side-effect of CDDP is nephrotoxicity. The cytotoxic action of
this drug is often thought to induce oxidative stress and be associated with its ability to bind DNA to form
CDDP–DNA adducts and apoptosis in kidney cells. In this study, the protective effect of cactus cladode extract
(CCE) against CDDP-induced oxidative stress and genotoxicity were investigated in mice. We also looked for levels
of malondialdehyde (MDA), catalase activity, superoxide dismutase (SOD) activity, chromosome aberrations (CA) test,
SOS Chromotest, expressions of p53, bax and bcl2 in kidney and we also analyzed several parameters of renal
function markers toxicity such as serum biochemical analysis.
Methods: Adult, healthy balb/c (20–25 g) male mice aged of 4–5 weeks were pre-treated by intraperitonial
administration of CCE (50 mg/Kg.b.w) for 2 weeks. Control animals were treated 3 days a week for 4 weeks by
intraperitonial administration of 100 μg/Kg.b.w CDDP. Animals which treated by CDDP and CCE were divided into
two groups: the first group was administrated CCE 2 hours before each treatment with CDDP 3 days a week for
4 weeks. The second group was administrated without pre-treatment with CCE but this extract was administrated
24 hours after each treatment with CDDP 3 days a week for 4 weeks.
Results: Our results showed that CDDP induced significant alterations in all tested oxidative stress markers. In
addition it induced CA in bone morrow cells, increased the expression of pro-apoptotic proteins p53 and bax and
decreased the expression of anti-apoptotic protein bcl2 in kidney. On the other hand, CDDP significantly increased
the levels of urea and creatinine and decreased the levels of albumin and total protein.The treatment of CCE before
or after treatment with CDDP showed, (i) a total reduction of CDDP induced oxidative damage for all tested
markers, (ii) an anti-genotoxic effect resulting in an efficient prevention of chromosomal aberrations compared to
the group treated with CDDP alone (iii) restriction of the effect of CDDP by differential modulation of the
expression of p53 which is decreased as well as its associated genes such as bax and bcl2, (iiii) restriction of serums
levels of creatinine, urea, albumin and total protein resuming its values towards near normal levels of control.
Conclusion: We concluded that CCE is beneficial in CDDP-induced kidney dysfunction in mice via its anti-oxidant
anti-genotoxic and anti-apoptotic properties against CDDP.
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CDDP (cis-dichlorodiammineplatinum (II), CDDP) is a
synthetic anticancer drug extensively used clinically for
the treatment of several human malignancies such as
ovarian, testicular, bladder, head and neck, and uterine
cervix carcinomas [1-3]. Various data indicate that
CDDP induces oxidative stress, lipid peroxides [4] and
DNA damage [5,6]. Also, there is evidence suggesting
that the generation of free radicals causes nephrotoxic
effects by CDDP [7,8]. There is a continuous search for
agents that provide nephroprotection against CDDP and
other platinum drugs; these include antioxidants, modu-
lators of nitric oxide, diuretics, and cytoprotective and
apoptotic agents [9]. However, none of these were found
to be suitable/safe for clinical use in protecting against
CDDP-induced nephrotoxicity.
In the past few years, much interest has been centered
on the role of naturally occurring dietary substances for
the control and management of various chronic diseases
[10,11] such as cactus Opuntia ficus indica which grows
all over the semiarid countries and is mainly cultivated
for its fruit (cactus pear) and cladode which are rich in
nutritional compounds [12]. In Chinese medicine cactus
pear is used against inflammation and snakebite [13].
Different parts of Opuntia ficus-indica are used in the
traditional medicine in several countries: the cladodes
are utilized to reduce serum cholesterol level and blood
pressure, for treatment of ulcers, rheumatic pain and
kidney conditions [14]. The fruits have shown antiul-
cerogenic [15] and neuroprotective activity [16].
But a few studies have examined the cytoprotective ef-
fect of cladodes that is why we chose CCE against tox-
icity of CDDP.
Taking into consideration the potential clinical use of
CDDP and the numerous health benefits of CCE. The
aim of the present study was to find out the eventual
protective effect of CCE against CDDP-induced oxida-
tive stress and genotoxicity and nephrotoxicity in vivo
using balb/c mice. We evaluated the antioxidant and
antigenotoxic potential CCE against CDDP. To this end
we also measured (i) levels of MDA, level of catalase and
SOD activity, evaluated (ii) chromosome aberrations,
p53, bax and bcl2 protein expressions we also analyzed
several parameters of renal function markers toxicity. It
is also of interest to find whether there is any correlation
between total phenolic and total flavonoid contents of
plant extract and the different activities.
Methods
Chemicals
CDDP salt (cis-diamineplatinum (II) dichloride, CAS no.
15663-27-1) was purchased from Sigma–Aldrich Chem-
ical Co. (St. Louis, MO, USA). It was dissolved in water.
Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate disodium salt (BCIP) were from Sigma
Aldrich, France. Mouse monoclonal anti-p53, anti-bax
and anti-bcl2 and the secondary antibody (phosphatase-
conjugated) were from Invitrogen. All other chemicals
used were of the highest grade available from commer-
cial sources.
Extract of cactus cladodes
Young cactus cladodes of Opuntia ficus-indica (2–3 weeks
of age) collected from the local area were washed with
water chopped into small pieces and then pressed
using a hand-press, homogenized with 10 mM Tris–
HCl, pH 7.4 at 4°C and centrifuged 30 min at 3500 g
at 4°C. The supernatant was collected and lyophi-
lized. Prior to use, the lyophilized extract was dis-
solved in water.
Determination of total polyphenol and flavonoid contents
The polyphenol content of CCE was quantified by the
Folin–Ciocalteau reagent [17,18]. Aliquots of test sam-
ples (100 μl) were mixed with 2.0 ml of 2% Na2CO3 and
incubated at room temperature for 2 min. After the
addition of 100 μl 50% Folin–Ciocalteau phenol
reagents, the reaction tube was further incubated for
30 min at room temperature, and finally absorbance was
read at 720 nm. Gallic acid (0.2 mg/ml) was used as a
standard. Polyphenol content was expressed according









A known volume of extract was placed in a 10-ml
volumetric flask to estimate flavonoid content according
to the modified method of Zhishen et al. (1999) [19].
After addition of 75 μl of NaNO2 (5%), 150 μl of freshly
prepared AlCl3 (10%), and 500 μl of Na OH (1 N), the
volume was adjusted with distilled water until 2.5 ml.
After 5 min incubation, the total absorbance was mea-
sured at 510 nm. Quercetin (0.05 mg/ml) was used as a
standard compound. Flavonoid content was expressed







Determination of tannin content
The method described by Pearson, (1976) [20] was used
for the determination of tannin content of samples. Ex-
traction of tannin from the samples was achieved by dis-
solving 5 g of each sample in 50 ml of distilled water in
a conical flask, allowing the mixture to stand for 30 min
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trifuging at 5000 g to obtain a supernatant (tannin ex-
tract). The extract was diluted to 100 ml in a standard
flask using distilled water. 5 ml of the diluted extract
and 5 ml of standard tannic acid (0.1 g/l) were measured
into 50 ml volumetric flask. 1 ml of Folin–Denis reagent
was added to each flask followed by 2.5 ml of saturated
sodium carbonate solution. The solutions were made up
to the 50-ml mark with distilled water and incubated at
room temperature (20–30°C) for 90 min. The absorption
of these solutions was measured against that of the re-
agent blank (containing 5 ml distilled water instead of
extract or standard tannic acid solution) in a Genesys
(Wisconsin USA) spectrophotometer at 760 nm wave-
length. Tannin content determination assay was tested







where E: molar extinction coefficient (l g-1 cm-1) of tan-
nic acid (3.27 L g-1 cm-1).
DPPH radical scavenging assay
Radical scavenging activity (RSA) of the CCE was mea-
sured using the free radical α, α-diphenyl-b-picrylhydrazyl
(DPPH) [22]. According to the method, 0.1 g of the sam-
ple was extracted in 2.9 ml of methanol by centrifuging at
5000 rpm for 15 min. The content was filtered through
Whatman No.1 filter paper. Methanolic DPPH (0.5 ml,
500 μM) was added to the tubes containing this super-
natant and shaken vigorously. The tubes were incubated
at room temperature for 45 min in the darkness. Vitamin
E was used as a reference compound in the same concen-
tration range as the test compounds.
The changes in optical density (OD) of the samples
were measured at 515 nm with methanol as blank. RSA
was expressed as the percentage inhibition of DPPH rad-
ical and calculated using the following formula:
% Radical scavenging activity DPPHð Þ
¼ Control OD Sample ODð Þ
Control OD
 100
When DPPH reacts with an antioxidant compound,
which can donate hydrogen, it is reduced. The changes
in colour (from deep—violet to light—yellow) were mea-
sured at 515 nm on a UV/visible light spectrophotom-
eter (Spectronic Genesys).
Animals and treatments
Adult, healthy balb/c (20–25 g) male mice aged of
4–5 weeks provided from an animal breeding centre
(SEXAL St. Doulchard, France following the agreementof the Ethics Committee named National committee of
Medical ethics CNEM, BP 74 - Pasteur Institute Tunis
1002 TUNISIA) were used. The animals were kept for
acclimatization 1 week under constant conditions of
temperature and a light/dark cycle of 12 h: 12 h. Ani-
mals had free access to standard granulated chow and
drinking water.
All animals were divided in 8 groups of 6 animals per
group and treated as follows:
Group 1: Mice given H2O (100 μl) by intraperitonial
route (ip)
Group 2: Mice given CCE 50 mg/Kg b.w (ip) for
45 days.
Group 3: Mice given CDDP 100 μg/Kg b.w for15 days
treatment.
Group 4: Mice are pre-treated with only CCE for
15 days and they given CDDP 100 μg/Kg b.w +CCE
50 mg/Kg b.w for other 15 days (second treatment
with CCE is before 2 hours injection with CDDP).
Group 5: Mice are pre-treated with only CCE for
15 days and they given CDDP 100 μg/Kg b.w +CCE
50 mg/Kg b.w for other 15 days (second treatment
with CCE is after 24 hours injection with CDDP). NB:
Groups 6, 7 and 8 are not pre-treated with CCE
Group 6: Mice given CDDP 100 μg/Kg b.w for 30 days
treatment
Group 7: Mice given CDDP 100 μg/Kg b.w +CCE
50 mg/Kg b.w (before 2 hours injection with CDDP
for 30 days treatment)
Group 8: Mice given CDDP 100 μg/Kg b.w +CCE
50 mg/Kg b.w (after 24 hours injection with CDDP for
30 days treatment).
At the end of the experiment, animals were sacrificed
under light ether anesthesia by decapitation and the kid-
neys were immediately removed.
Evaluation of lipid peroxidation status
Lipid peroxidation was determined indirectly by measur-
ing the production of MDA in the renal extracts follow-
ing the method of Aust et al. (1985) [23]. Briefly, 200 μl
of kidney extracts were mixed with 150 μl of TBS (Tris
50 mM and NaCl 150 mM, pH 7.4) and 250 μl TCA–
BHT (20% TCA and BHT 1%). The mixture was vigor-
ously vortexed and centrifuged at 1500 g for 10 min.
400 μl of the supernatant were added with HCl 0.6 N
and 320 μl Tris-TBA (Tris 26 mM and TBA 120 mM),
the content was mixed and incubated 10 min at 80°C.
The absorbance was measured at 535 nm. The optic
density corresponding to the complex formed with the
TBA–MDA is proportional to the concentration of
MDA and to the lipid peroxide. The concentration of
μmol of MDA/mg of proteins is calculated from the
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cient of MDA 1.56 × 105 M-1 cm-1.
Determination of catalase activity
Catalase activity was measured in the kidney extracts at
240 nm, according to Clairbone (1985) [24]. Briefly, 20 μl
of the extracts were added in the quartz cuvette contain
780 μl phosphate buffer and 200 μl of H2O2 0.5 M. The
activity of catalase was calculated using the molar extinc-
tion coefficient (0.04 Mm-1 cm-1). The results were
expressed as μmol of H2O2/min/mg of proteins.
Determination of SOD activity
Kidney tissue was homogenized with 10 volumes of ice-
cold 1.15% KCl buffer containing 0.4 Mm PMSF and
was centrifuged at 2000 rpm for 10 min (4°C). Total
(Cu–Zn and Mn) SOD activity was determined accord-
ing to Sun et al. (1988) [25]. The method is based on the
inhibition of nitro blue tetrazolium (NBT) reduction by
the xanthine-xanthine oxidase system as a superoxide
generator. One unit of SOD was defined as the enzyme
amount causing 50% inhibition in the NBT reduction
rate. SOD activity was also expressed as units per milli-
gram protein (U/mg protein).
Chromosome aberration assay
24 hours before sacrifice, animals were given a suspension
of yeast powder (100 mg/500 μl) to accelerate mitosis of
bone-marrow cells. Vinblastine (200 μl; 250 μg/ml) was
injected into the animals 45 min before sacrifice in order
to block dividing cells in metaphasis. Bone-marrow cells
from femurs and tibias were collected, subjected to hypo-
tonic shock (KCl 0.075 M) and fixed three times using
methanol-acetic acid [26]. The cells were spread on glass
slides that were blazed on a flame for 5s, then air-dried for
conservation at room temperature and finally stained by
4% dilution of Giemsa reagent in water for 15 min. After
coding of the slides, the chromosomes of 100 cells in
metaphase were examined for abnormalities at a magnifi-
cation of 1000× using an optical microscope (Carl Zeiss,
Germany). This was done for each one of three replicates
(300 metaphases per dose level) for negative controls,
positive controls and treated groups. Chromosome aberra-
tions were identified according to criteria described by
Savage (1975) [27]. Metaphases with chromosome breaks,
gaps, rings and centric fusions (robertsonian transloca-
tion) were recorded and expressed as percentage of total
metaphases per group.
Activation mixture
The S9 microsome fraction was prepared from the liver
of rats treated with Aroclor 1254 [28]. The composition
of the activation mixture is the following per 10 ml of S9
mix: salt solution (1.65 M KCl + 0.4 M MgCl2 6H2O)0.2 ml; G6P (1 M) 0.05 ml; NADP (0.1 M) 0.15 ml; Tris
buffer (0.4 M pH7.4) 2.5 ml; Luria broth medium 6.1 ml;
S9 fraction 1 ml.
Sos chromotest
The SOS chromotest assay is a bacterial test for detect-
ing DNA damaging agent. It was employed to determine
the effect of cactus cladode extract on the genotoxicity
of aflatoxin B1 (direct acting mutagen) induced geno-
toxicity. The SOS chromotest with Escherichia coli
PQ37strain was performed according to the procedure
described by Quillardet and Hofnung (1985) [29]. The
genotype of this strain is: F-thr leu his-4 pyrD thi galE
galK lacDU169 Srl300 Tn10 rpoB rpsL uvrA rfa trp
Muc + sfiA::Mud (Ap, lac) cts. An exponential-phase cul-
ture of E. coli PQ37 was grown at 37°C in LB medium
to an approximate cell density of 2.108 cell/ml supple-
mented with ampicillin (20 μg/ml). One ml of this cul-
ture was diluted with 9 ml of fresh medium; Positive
controls were prepared by exposure of the bacteria to
CDDP. After 2 h of incubation at 37°C, with shaking,
300 μl samples were used for assaying β-galactosidase
(β-gal) and alkaline phosphatase (AP) activities. In this
assay, the β-galactosidase synthesis (lacZ gene) is
dependent on sfiA activation and is used to measure in-
duction of SOS repair system. The activity of the consti-
tutive enzyme alkaline phosphatase was used as a
measure of protein synthesis and toxicity. Enzyme activ-
ities were assessed spectrophotometrically. The SOS in-
duction factor (IF) in treated cells was obtained by
comparing β-galactosidase and alkaline phosphatase ac-
tivities in treated and untreated cells. The result was
considered positive when the IF for β-galactosidase ac-
tivity was >2.0. For evaluation of the protective effect of
CCE on the induction of the SOS response by CDDP (in
the presence of the S9 activation mixture), 10 μl of
CDDP (10 μg/assay) were added into tubes with 10 μl of
the tested concentration of CCE. Antigenotoxicity was
expressed as percentage inhibition of genotoxicity
induced by CDDP according to the formula:





where IF1 is the induction factor in the presence of the
test compound and the genotoxin, IF2 the induction fac-
tor in the absence of the test compound and in the pres-
ence of the genotoxin, and IF0 is the induction factor of
the negative control. Data were collected as a mean±S.D.
of experiments.
Protein extraction and Western blot analysis
Equal amounts of proteins (20 μg) were separated by
12% SDS-polyacrylamide gel electrophoresis. Separated
Table 1 Quantitative polyphenols, flavonoids and tannins
of cactus cladode extract
Metabolites Cactus cladode extract
Total polyphenols μg (Gallic acid equivalents) 600,18 ± 6,1
Flavonoids μg (Quercetin equivalents) 223,04 ± 2,2
Tannins μg (Tannic acid equivalent) 53,33 ± 0,5
Brahmi et al. BMC Complementary and Alternative Medicine 2012, 12:111 Page 5 of 14
http://www.biomedcentral.com/1472-6882/12/111proteins were electro-blotted on nitrocellulose mem-
brane in the transfer buffer (10 ml Tris-base, pH 8.3,
96 mM glycine and 10% methanol). The membrane was
then blocked in TBS (20 mM Tris–HCl, Ph 7.5, 500 mM
sodium chloride) containing 5% of BSA, washed in TBS
(TBS containing 0.3% Tween 20) and probed with an
antibody for p53 or bax or bcl2 at a 1:1000 dilution for
6 h at room temperature. The membrane was then
washed and incubated with goat anti-mouse alkaline
phosphate conjugated at a 1:3000 dilution for 1 h. Next,
the membrane was washed and the chromogenic sub-
strate BCIP/NBT was added to localize antibody bind-
ing. P53, bax and bcl2 levels were then determined by
computer-assisted densitometric analysis (Densitometer,
GS-800, BioRad Quantity One).
Biochemical assay
Creatinine, urea were performed spectrophotometrically
using an autoanalyzer (Opera, Techicon, Bayer, USA).
Total protein was determined in plasma samples by the
Biuret method according to Gornall et al. (1949) [30].
Albumin concentration was determined by the method
of Doumas et al. (1977) [31].
Statistical analysis
Experimental values are expressed as mean± SD. Com-
parison of mean values between groups was performed
by one way-analysis of variance (oneway-ANOVA) fol-
lowed by post- hoc Tukey test. Expression of p53, baxFigure 1 Radical scavenging activity of CCE by DPPH method. CCE anand bcl2 were determined by Kruskal–Wallis Test. The




Determination of total polyphenol, flavonoid and tannin
contents
The phytochemical study of CCE showed the presence
of various quantities of polyphenols, flavonoids and tan-
nins (Table 1). Ours results showed that 1 mg of cladode
extract was equivalent to 600 μg of gallic acid, 223 μg of
quercetin and 53 μg of tannic acid.
Radical-scavenging activities
The radical scavenging activity was evaluated by the
DPPH assay. DPPH is a molecule containing a stable
free radical; In the presence of an antioxidant that can
donate an electron to DPPH, the purple color typical of
the free DPPH radical decays, a change that can be fol-
lowed spectrophotometrically at 517 nm. This simple
test can provide information on the ability of a com-
pound to donate an electron, the number of electrons a
given molecule can donate, and on the mechanism of
antioxidant action.
The radical-scavenging activity of CCE, measured as
decolorizing effect following the trapping of the un-
paired electron of DPPH, is shown in Figure 1. The CCE
has a potent radical scavenger with a percentage de-
crease versus the absorbance of DPPH standard solution
of 76.11%.
Effect of CCE on oxidative stress induced by CDDP
Evaluation of lipid peroxidation status
Animals were injected with CDDP (100 μg/kg (b.w)) to
investigate the lipid peroxidation; Results of the effect of
CDDP alone and jointly with CCE on the induction ofd vitamin E (Vit E), *p<0.05.
Figure 2 Lipid peroxydation as determined by MDA level in kidney of balb/c mice exposed to CDDP (100 μg/Kg b.w) for 15 days then
30 days and prevention by CCE (50 mg/Kg b.w) before or after CDDP administration. Results were expressed as means ± S.D. from
independent experiments. Significantly different p<0.05. * indicated significant difference (p<0.05) from control. For 15 days of treatment: Mice
given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg b.w+CCE 50 mg/Kg b.w (pre-treatment) and Mice given CDDP 100 μg/Kg b.w +CCE
50 mg/Kg b.w (post-treatment). For 30 days of treatment: Mice given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg b.w+CCE 50 mg/Kg
b.w (pre-treatment) and Mice given CDDP 100 μg/Kg b.w +CCE 50 mg/Kg b.w (post-treatment).
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are shown in Figure 2, after 15 days of exposure, MDA
levels increased significantly in kidney extracts of mice
treated with CDDP (15.25 ± 0.30 nmol/ml), on days 30,
MDA levels is (19.03 ± 0.12 nmol/ml) compared with the
control value (7.68 ± 0.15 nmol/ml). However, the pre or
post-treatment with CCE (50 mg/kg b.w) before or after
treatment with CDDP induced a sharp decrease in MDA
level was noticed in both times 15 days and 30 days,
MDA level has decreased significantly to reach the con-
trol level.
Determination of catalase activity
Figure 3 illustrates the effect of CDDP and CCE on cata-
lase activity. CDDP induced a marked decrease in cata-
lase activity after 15 days and 30 days exposure on
kidney extracts at day 30 lowest level of catalase activity
was observed by 25,3 U/mg protein, but both before and
after CDDP exposure the CCE striking increase of this
activity was noticed and duplicated in kidney with CCE
treatment.*
Figure 3 Effect of CCE (50 mg/Kg b.w), before and after treatment by
Significantly different, p<0.05. Results were expressed as means ± S.D. *indic
treatment: Mice given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/K
100 μg/Kg b.w+CCE 50 mg/Kg b.w (post-treatment). For 30 days of treatm
b.w+CCE 50 mg/Kg b.w (pre-treatment) and Mice given CDDP 100 μg/KgDetermination of SOD activity
Figure 4 illustrates the effect of CDDP and CCE on
SOD activity, CDDP induced a marked decrease in SOD
activity after 15 days and 30 days exposure on kidney
extracts by 0.056 U/mg proteins at 30 days of CDDP
treatment, but the pre and post-treatment by CCE in-
crease significantly the level of SOD activity to reach
the control level.
Effect of CCE on DNA damage induced by CDDP
Eventual prevention of CDDP-induced chromosome
aberrations by CCE
Genotoxicity of CDDP was assessed through test of
chromosome aberrations in mice bone marrow cells.
Results of the visual scoring of total DNA damage
induced by CDDP are shown in Figure 5. We observed
that animals treated with CDDP alone (100 μg/kg b.w)
showed a significant increase in chromosome aberra-
tions in bone marrow cells especially on day 30 with
42% of chromosome aberrations. Control groups which
were treated with H2O, or CCE showed a similar basalCDDP (100 μg/Kg b.w) induced catalase enzyme activity in mice.
ated significant difference (p<0.05) from control. For 15 days of
g b.w +CCE 50 mg/Kg b.w (pre-treatment) and Mice given CDDP
ent: Mice given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg
b.w+CCE 50 mg/Kg b.w (post-treatment).
Figure 4 Effect of CCE (50 mg/Kg b.w), before and after treatment by CDDP (100 μg/Kg b.w) induced SOD enzyme activity in mice.
Significantly different, p<0.05. Results were expressed as means ± S.D. * indicated significant difference (p<0.05) from control. For 15 days of
treatment: Mice given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg b.w +CCE 50 mg/Kg b.w (pre-treatment) and Mice given CDDP
100 μg/Kg b.w+CCE 50 mg/Kg b.w (post-treatment). For 30 days of treatment: Mice given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg
b.w+CCE 50 mg/Kg b.w (pre-treatment) and Mice given CDDP 100 μg/Kg b.w+CCE 50 mg/Kg b.w (post-treatment).
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(respectively 3.78± 1.5 and 3.67 ± 1.78). But we remarked
that the co-administration of cactus before or after CDDP
treatment decreased significantly the total chromosomal
aberrations.
The SOS chromotest assay
Experiments realized with CCE revealed no genotoxi-
city induction in so far as the induction factor is not
higher than 1.5. While experiment with CDDP give
the maximum of genotoxicity with IF =3.24 similar to
genotoxic effect of aflatoxin B1considered a positive
control of genotoxicity with IF =4.24. The inhibitory
effect of the tested product on the genotoxicity
induced by CDDP using the SOS chromotest is illu-
strated by Table 2. This study shows that CCE present
an antigenotoxic effect at the tested concentrations. In-
deed CCE treatment significantly decreases the IF of
CDDP by 58%.Figure 5 Effect of cactus cladodes on chromosomal aberrations in bo
significant difference (p<0.05) from control. For 15 days of treatment: Mice
50 mg/Kg b.w (pre-treatment) and Mice given CDDP 100 μg/Kg b.w+CCE
CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg b.w +CCE 50 mg/Kg
50 mg/Kg b.w (post-treatment).Effect of CCE on apoptosis status
Determination of p53 expression
Figure 6a and 6b showed the Western blotting and densi-
tometry analysis of p53 expression in kidney of controls
and treated animals. After 15 days and 30 days exposure
to CDDP alone, p53 expression was found to be signifi-
cantly increased compared to controls but it decreased by
CCE pre or post-treatment. The CCE treated group did
not have any significant effect on the expression of p53
(Additional file 1).
Determination of bax expression
CDDP induces the expression of bax genes in kidney as
evidenced by example of immunoblotting illustrated in
Figure 7a, which was further, confirmed by results of
scanning densitometry (Figure 7b). The administration
of CCE before and after CDDP exposure for 15 and
30 days treatment decreased the amounts of bax
(Figure 7a and 7b). The CCE treated group did not have
any significant effect on the expression of bax.ne marrow cells of CDDP treated balb/c mice. * indicated
given CDDP 100 μg/Kg b.w or Mice given CDDP 100 μg/Kg b.w+CCE
50 mg/Kg b.w (post-treatment). For 30 days of treatment: Mice given
b.w (pre-treatment) and Mice given CDDP 100 μg/Kg b.w +CCE
Table 2 Genotoxic activity of cactus cladode extract and
CDDP by the SOS chromotest in the presence of E.coli
PQ37
Extract β-gal (U) AP (U) IF
NC 0,65 ± 0,001 1,9 ± 0,001
AFB1 9,21 ± 0,005 2,5 ± 0,003 4,24
CDDP 1,98 ± 0,004 2,5 ± 0,002 3,24
CCE 1,1 ± 0,002 1,7 ± 0,001 0,73
CDDP+CCE 1,56 ± 0,002 1,25 ± 0,002 1,35
β-gal β-galactosidase, AP alkaline phosphatase, U enzyme units, IF induction
factor, NC negative control (non treated cells). AFB1 aflatoxin B1. (Positive
control of genotoxicity).
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Figure 8a and 8b shows the western blotting and densi-
tometry analysis of bcl2 expression in kidney of controls




1     2
Figure 6 Immunoblot (a) and densitometric (b) analysis of p53 in kidn
12% SDS-PAGE and blotted with anti-p53 antibody. The intensity of the pro
made to blots by adjusting the luminosity and contrast of the protein band
versions of Western blot have been included as an Additional file 1: Figure
(p<0.005). The results are representative of eight independent experiments
50 mg/Kg b.w (3) Animals treated 15 days by CDDP 100 μg/Kg b.w (4) Ani
exposure for 15 days treatment (5) Animals treated by CCE 50 mg/Kg b.w
treated 30 days by CDDP 100 μg/Kg b.w (7) Animals treated by CCE 50 mg
(8) Animals treated by CCE 50 mg/Kg b.w after CDDP 100 μg/Kg b.w expoto CDDP alone, anti-apoptotic protein bcl2 expression
was found to be significantly decreased by 60% after
CDDP treatment compared to controls, but it increased
before or after treatment by CCE. The CCE treated
group did not have any significant effect on the expres-
sion of bcl2 (Additional file 1).Effect of CCE on CDDP-induced nephrotoxicity
parameters in serum
CCE alone had no effect on serum creatinine, urea, albu-
min and total protein. The administration of CDDP
(100 μg/kg bw) to mice caused significant increase in
blood levels of creatinine and urea and decreased signifi-
cantly blood levels of albumin and total protein. When
CCE was given to CDDP mice, CDDP elicited nephro-
toxic alterations appeared to be ameliorated. In fact,      3       4     5      6       7     8     
ey of control and treated animals. The protein was separated on
tein band was scanned by densitometry. Some modifications are
s to better understand the effects of CDDP and CCE (unmodified
S1). Results are significantly different as compared to controls
: (1) Animals treated by 100 μl H2O (2) Animals treated by CCE
mals treated by CCE 50 mg/Kg b.w before CDDP 100 μg/Kg b.w
after CDDP 100 μg/Kg b.w exposure for 15 days treatment (6) Animals
/Kg b.w before CDDP 100 μg/Kg b.w exposure for 30 days treatment
sure for 30 days treatment.
(a)
(b)            
1     2      3 4 5 6 7     8     
Bax
Tubulin
Figure 7 Immunoblot (a) and densitometric (b) analysis of bax in kidney of control and treated animals. The protein was separated on
12% SDS-PAGE and blotted with anti-bax antibody. The intensity of the protein band was scanned by densitometry. Results are significantly
different as compared to controls (p<0.005). The results are representative of eight independent experiments: (1) Animals treated by 100 μl H2O
(2) Animals treated by CCE 50 mg/Kg b.w (3) Animals treated 15 days by CDDP 100 μg/Kg b.w (4) Animals treated by CCE 50 mg/Kg b.w before
CDDP 100 μg/Kg b.w exposure for 15 days treatment (5) Animals treated by CCE 50 mg/Kg b.w after CDDP 100 μg/Kg b.w exposure for 15 days
treatment (6) Animals treated 30 days by CDDP 100 μg/Kg b.w (7) Animals treated by CCE 50 mg/Kg b.w before CDDP 100 μg/Kg b.w exposure
for 30 days treatment (8) Animals treated by CCE 50 mg/Kg b.w after CDDP 100 μg/Kg b.w exposure for 30 days treatment.
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mice seemed to restore serums levels of creatinine, urea,
albumin and total protein resuming its values towards
near normal levels of control (Table 3).
Discussion
CDDP is an extensively used anti-cancer agent for the
management of germ cell tumors, head and neck can-
cers, bladder cancer, cervical cancer and as a salvage
treatment for other solid tumors [32]. Although higher
doses of CDDP are more efficacious for the suppression
of cancer but high dose therapy manifests irreversible
renal dysfunction [33] and damage to non-tumor cells.
The concept of cancer and chronic kidney diseases pre-
vention using naturally occurring substances that can be
included in the diet consumed by the human population
is gaining increasing attention. In this line, different
types of fruits and vegetables have been re-evaluated
and recognized as valuable sources of nutraceuticals.Polyphenolic compounds are abundant in foods of plant
origin. The application of such bioactive plant compo-
nents may increase the stability of foods and, at the
same time, improve their health properties associated
with anti-cancer, antiallergic and anti-inflammatory ac-
tivities of polyphenols in the human body [34-36].
The total polyphenol content of the cladode extracts
from Opuntia ficus indica was expressed as gallic acid
equivalents. The total flavonoids contents of the CCE is
determined by using the method of Zhishen et al. (1999)
[19] and expressed as quercetin equivalents [37,38]. Sig-
nificantly high total polyphenols and flavonoids content
of the CCE may be corroborated with the observed anti-
oxidant and antigenotoxic activities (Table 1).
The present study was performed to test the hypoth-
esis that CCE would ameliorate CDDP induced oxidative
stress and genotoxicity causes of nephrotoxic effect
allowing the clinical use of CDDP in the treatment of
various malignancies and minimizing its side effects. To
(a)
(b)
1     2      3 4 5 6        7     8     
Bcl2
Tubulin
Figure 8 Immunoblot (a) and densitometric (b) analysis of bcl2 in kidney of control and treated animals. The protein was separated on
12% SDS-PAGE and blotted with anti-bcl2 antibody. The intensity of the protein band was scanned by densitometry. Some modifications are
made to blots by adjusting the luminosity and contrast of the protein bands to better understand the effects of CDDP and CCE (unmodified
versions of Western blot have been included as an Additional file 1: Figure S1). Results are significantly different as compared to controls
(p<0.005). The results are representative of eight independent experiments: (1) Animals treated by 100 μl H2O (2) Animals treated by CCE
50 mg/Kg b.w (3) Animals treated 15 days by CDDP 100 μg/Kg b.w (4) Animals treated by CCE 50 mg/Kg b.w before CDDP 100 μg/Kg b.w
exposure for 15 days treatment (5) Animals treated by CCE 50 mg/Kg b.w after CDDP 100 μg/Kg b.w exposure for 15 days treatment (6) Animals
treated 30 days by CDDP 100 μg/Kg b.w (7) Animals treated by CCE 50 mg/Kg b.w before CDDP 100 μg/Kg b.w exposure for 30 days treatment
(8) Animals treated by CCE 50 mg/Kg b.w after CDDP 100 μg/Kg b.w exposure for 30 days treatment.
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treatment by CCE 50 mg/kg b.w in balb/c mice. The
intraperitonial route for administration of the CCE in
this dose was chosen based on reports in our studies
which have shown that after testing several doses of cac-
tus this dose is appropriate to induce a good prevention
against oxidative stress induced by mycotoxine zearale-
none in balb/c mice [39,40].
To evaluate the oxidative status, we looked for an even-
tual lipid peroxidation which constitutes one of the most
common indices used to assess oxidative stress. MDA is
the end product of lipoperoxydation, considered as a late
biomarker of oxidative stress and cellular damage [41,42].
In the present study, exposure to CDDP induces a marked
increase in MDA formation in kidney but administration
of CCE significantly reduced MDA level which dropped
to the control level (Figure 2). Yuce et al. (2007) andAl-Majed et al. (2006) [43,44] have also reported an in-
crease in MDA and a decrease in the activities of anti-
oxidant enzyme upon similar CDDP treatment of rats.
Also we looked for measured level of antioxidant
enzymes catalase activity and SOD activity, were sig-
nificantly (p<0.005) decreased compared to control
(Figures 3 and 4); Yuce et al. (2007) [43] reported a simi-
lar decrease of antioxidant enzymes catalase and SOD
by CDDP treatment in vivo. Also several investigators
have demonstrated that CDDP induces ROS in renal
epithelial cells primarily by decreasing the activity of
antioxidant enzymes and by depleting intracellular con-
centrations of GSH, catalase and SOD activities [45,46].
The presence of CCE with CDDP by pre or post treat-
ment normalized the levels of the antioxidant enzyme
catalase and SOD to nearly the normal values of control.
CCE ability to prevent and protect against oxidative














Creatinine (mg/dl) 0,8 ± 0,14 0,75 ± 0,1 1,79 ± 0,0045* 0,56 ± 0,005* 0,88 ± 0,0048* 2,13 ± 0,005* 0,87 ± 0,0044 0,95 ± 0,0052
Urea (mg/dl) 52,34 ± 0,12 51,54 ± 0,17 79,13 ± 0,12* 58,5 ± 0,14* 60,13 ± 0,19* 94,2 ± 0,12* 60,12 ± 0,18 68,5 ± 0,15
Albumin (g/dl) 10,44 ± 0,14 10,72 ± 0,15 8,01 ± 0,17* 9,8 ± 0,14* 8,48 ± 0,18* 7,12 ± 0,16* 9,91 ± 0,12 9,24 ± 0,16
Total protein (g/dl) 9,95 ± 0,19 9,78 ± 0,21 7,12 ± 0,25* 8,67 ± 0,19* 8,03 ± 0,26* 6,2 ± 0,193* 8,7 ± 0,23 8,12 ± 0,26
Experimental values are expressed as mean ± SD. Comparison of mean values between groups was performed by one way-analysis of variance (oneway-ANOVA)
(*) significantly different from control at p<0.05.
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antioxidants such as ascorbic acid, flavonoids and phen-
olic acids actually detected in cladodes (Table 1) and in
fruit [47-50].
Oxidative stress is important as direct and indirect ini-
tiator as well as promoter of genotoxicity and apoptotic
process. The above genotoxic endpoints are well known
markers of genotoxicity and any reduction in the fre-
quency of these genotoxic endpoints gives an indication
of the antigenotoxicity of a particular compound [51]. In
addition, for the different studied genotoxic endpoints,
the concentration of cactus (50 mg/kg b.w.) was not
genotoxic itself. In the current study, we tested the
chromosomal aberrations assay which is widely used test
to assess genotoxicity of chemicals. We have demon-
strated that mice that received CDDP significantly in-
crease the percentage of chromosome aberrations in
bone marrow cells (Figure 5). The most frequent types
of aberrations observed in the present study were
chromosome breaks (Table 4), but gaps were also
observed. Chromosome breaks were classified as chro-
matid or isochromatid. It is acknowledged that CDDP
causes intrastrand and interstrand cross linking, prob-
ably between N7 and O6 of the adjacent guanine mole-
cules, which results in local denaturation of the DNA
chain [52]. Mice pre and post treated by CCE showed a
significant reduction the percentage of chromosome
aberrations in their bone marrow cells and the protec-
tion was around 50% and 70% respectively on 15 andTable 4 Percentage of different type of chromosomal damage
extract before or after treatment with CDDP
Experimental groups Centric fusion Ring
H2O 1,5 ± 1,25 1,00 ± 0,43
CCE 1,67 ± 0,75 1 ± 1,33
CDDP 15 days 2,13 ± 0,28* 1 ± 0,17
CDDP+CCE Pre-treatment 1,66 ± 0,55* 0 ± 0,17
CDDP+CCE Post-treatment 2,03 ± 1,5* 1 ± 0,33
CDDP 30 days 5 ± 1,77* 2,66 ± 2,67
CDDP+CCE Pre-treatment 3 ± 1,48* 1,33 ± 0,58
CDDP+CCE Post-treatment 2 ± 1,78* 1 ± 0,25
(*) Significant compared with group 1(H2O) (P<0.05).30 days treatment (Figure 4). The cytotoxic action of this
drug is often thought to be associated with its ability to
bind DNA to form CDDP–DNA adducts [53].
The absence of genotoxicity is not a characteristic of
all natural products in use, since other medicinal plants,
assayed with the SOS chromotest have resulted posi-
tively in genotoxicity [54]. These tests showed that
CDDP present a genotoxic effect and that the treatment
with CCE is able to remove this genotoxicity (Table 2).
The preliminary chemical study of CCE of Opuntia
ficus indica, revealed the presence of important quan-
tities of polyphenol compounds flavonoids and tannins
in aqueous extracts. These results could be correlated to
the antigenotoxic activity detected in this extract. In fact
the CCE showed significant anti-genotoxicity towards
CDDP. This suggests that CCE inhibit microsomal acti-
vation or that they directly protect DNA strands from
the electrophilic metabolite of the mutagen. They may
inhibit several metabolic intermediates and reactive oxy-
gen species (ROS) formed during the process of micro-
somal enzyme activation which are capable of breaking
DNA strands. Anti-genotoxic activity of CCE may be
ascribed to flavonoids [55] and tannins [56,57] which are
detected in our extract.
We cannot however, exclude the possibility that other
compounds with anti-genotoxic properties, participate in
the anti-genotoxic effect of CCE. On the other hand,
CCE exhibited a significant antioxidant activity towards
the free radical DPPH. These results were correlatedinduced by CDDP and reversed with cactus cladodes
Break Gap Total
3,28 ± 0,25 0 ± 0,00 3,78 ± 1,5
0 ± 0,00 1 ± 0,67 3,67 ± 1,78
10 ± 2,02* 2,13 ± 1,5* 15,26 ± 1,75*
6 ± 1,68* 1 ± 0,24 8,66 ± 1,53*
7,3 ± 1,45* 0 ± 0,00 10,33 ± 2,06*
* 20 ± 1,57* 5 ± 1,25* 32,66 ± 2,14*
* 5 ± 2,01* 1 ± 1,00* 10,33 ± 1,45*
* 6 ± 0,05* 3,58 ± 1,45* 12,58 ± 1,67*
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the chemical study of CCE, revealed the presence of im-
portant quantities of flavonoids. We believe that flavo-
noids are the most likely candidates among the
compounds known to be present CCE for preventing
oxidative lesions and providing antigenotoxic effect
[58,59]. These compounds may inhibit free radicals and
reactive oxygen species produced by CDDP.
The cytotoxicity of CDDP is believed to be due to the
formation of DNA adducts, which include DNA-protein
cross-links, DNA monoadducts, and interstrand and
intrastrand DNA cross-links [60,61]. Further studies
demonstrated that the cytotoxicity of CDDP is probably
due to a combination of insults, including mitochondrial
dysfunction [62], inhibition of protein synthesis [63] and
DNA injury [64]. It has recently reported that DNA
damage induced by CDDP leads to a rapid activation of
ataxia telangiec- tasia and Rad3-related (ATR) which
phosphorylates Chk2, a checkpoint kinase. ATR/Chk2
signaling is largely responsible for p53 phosphorylation
and activation during CDDP treatment and the p53 pro-
tein binds DNA [65].
Many studies have now documented the rapid activa-
tion and nuclear translocation of p53 in response to
CDDP both in kidneys [66] and in cultured renal prox-
imal tubular cells [67]. It is well known that both
CDDP-induced DNA damage and CDDP-induced oxi-
dant stress are potent activators of p53 [68,69], and that
p53 can in turn activate bax [70,71]. It is therefore likely
that this regulatory mechanism may play a crucial role
in CDDP-induced apoptosis.
In the present study, the modulatory effect of CCE
on CDDP toxicity was suggested to carry out through
alterations in cell death pathway, p53 and the ratio
of bax/bcl2 plays an important role in determining
whether cells will undergo apoptosis. Our results
showed that treatment by CDDP for 15 and 30 days
induced high expressions of p53 and bax, an apop-
totic marker in kidney tissues of CDDP treated mice
than controls and down-regulation of antiapoptotic
protein bcl2 (Figures 6a, 6b, 7a, 7b, 8a, 8b). Our
study showed that the CCE treatment after or before
CDDP treatment has been shown to induce an anti-
apoptotic effect via inhibition of p53 and bax expres-
sion (Figure 6a, 6b, 7a, 7b and 8a, 8b). This indicates
that CCE modulates the p53 dependent apoptotic
pathway to restrict the CDDP toxicity in kidneys.
Kidneys represent the major control system maintain-
ing body homeostasis. The plasma concentrations of
urea and creatinine determine renal function and are
thus biomarkers for kidney disease [72]. Mice treated
with CCE alone showed no significant change in the
levels of urea and creatinine compared to control. While,
CDDP treatment caused significant increase (p<0.05) inlevels of both parameters accompanied by significant de-
crease in blood levels of albumin and total protein. The
serum albumin concentration may be directly altered, as
results to loss albumin through damaged glomeruli in
case of renal failure [72]. Consequently, in the present
study, the significant decrease in albumin may be evi-
dence on CDDP-induced nephrotoxicity. Mice exposed
to CCE before or after CDDP exhibited a significant
(p<0.05) decrease in the levels of urea and creatinine
and increase levels of albumin and total protein; in fact,
CCE seemed to restore serums levels of creatinine, urea,
albumin and total protein resuming its values towards
near normal levels of control (Table 3). The increase in
both urea and creatinine levels due to CDDP treatment
has been previously reported by Shemida et al. (2005),
Iseri et al. (2007) and Mansour et al. (2002) [73-75].
Nephrotoxic damage by CDDP is indicated by increase
in blood urea and creatinine levels. Excretion of CDDP
is predominantly renal, and the kidney is considered to
be the primary target organ for CDDP toxicity. Conse-
quently, the impairment of kidney function by CDDP is
recognized as the main side effect and the dose limiting
factor associated with its use, occurring either acutely or
after repeated treatment [76].
Total protein concentration is likely to be decreased if
there is inhibition of protein synthesis or if degradation
of protein is promoting [77]. CDDP diminishes DNA,
RNA and protein synthesis. Ribosomal DNA accumu-
lates CDDP-induced DNA adducts. This is consistent
with the CDDP- induced injury. Moreover, CDDP-
induced transcription highjacking is another reason for
the inhibition of protein synthesis associated with
CDDP. Transcription highjacking refers to the conse-
quences of the ability of certain transcription factors
to bind to DNA adducts caused by organoplatinum
compounds. This leads to the sequestration of these
transcription factors from their usual promoter binding
sites [78].
Conclusion
In agents in the treatment of cancer. In spite of its clin-
ical usefulness, there are many occasions in which it is
difficult to continue the administration of the drug due
to its nephrotoxicity. In the present study, it is clear that
CDDP exposure resulted oxidative stress, genomic DNA
damage, apoptotic cell death in kidney, increased serum
creatinine and blood urea, and decreased levels of albu-
min and total protein biomarkers for kidney disease. But
CCE exposure prior and post to CDDP provided near
complete protection in terms of generation of oxidative
stress, genomic DNA integrity and modulate apoptosis
status. According to our results we noticed a similar ef-
fect between the pre and post treatment for the antioxi-
dant and antigenotoxic effects of CCE. Our results
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logical resistance to free radicals, suggesting the capacity
of this extract to play a role in antigenotoxic, anti-
apoptotic and anti-nephrotoxic effects of CCE. The pro-
tective effect of CCE makes them promising candidates for
further studies designed to obtain more evidence on their
components with potential chemo-preventive activity.
Additional file
Additional file 1: Figure S1. Unmodified versions of Immunoblot of
p53, bax and bcl2 in kidney of control and treated animals. The protein
was separated on 12% SDS-PAGE and blotted with anti-p53 antibody,
anti-bax antibody and anti-bcl2 antibody.
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